[go: up one dir, main page]

NO126368B - - Google Patents

Download PDF

Info

Publication number
NO126368B
NO126368B NO04900/68A NO490068A NO126368B NO 126368 B NO126368 B NO 126368B NO 04900/68 A NO04900/68 A NO 04900/68A NO 490068 A NO490068 A NO 490068A NO 126368 B NO126368 B NO 126368B
Authority
NO
Norway
Prior art keywords
gave
sulfate
ethanol
found
aminoethyl
Prior art date
Application number
NO04900/68A
Other languages
Norwegian (no)
Inventor
David Miller
Charles Sylvester Fake
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of NO126368B publication Critical patent/NO126368B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Forbindelsene som fremstilles ifølge oppfinnelsen kan foreligge som cis- og trans-isomerer og fremstillingen av disse former kommer også innenfor oppfinnelsens ramme. Da forbindelsene også inneholder asymmetriske karbonatomer, kan de foreligge i optisk aktive former, og disse former kommer også innenfor ram-men av oppfinnelsen. The compounds produced according to the invention can exist as cis- and trans-isomers and the production of these forms also falls within the scope of the invention. As the compounds also contain asymmetric carbon atoms, they can exist in optically active forms, and these forms also come within the scope of the invention.

Uttrykket "lavere alkyl" skal her bety alkylgrupper som The term "lower alkyl" shall here mean alkyl groups which

inneholder 1 til 6 karbonatomer. contains 1 to 6 carbon atoms.

Fremgangsmåten for fremstilling av forbindelsene av formelen (I) går ut på å la et pyrrolidinalkylamin av formelen (II): The method for preparing the compounds of the formula (I) involves adding a pyrrolidine alkylamine of the formula (II):

hvor R, R^ og har samme betydning som foran nevnt, eller et salt herav, omsettes med et S-alkylisotiourinstoff, et O-alkylisourin-stoff eller et syreaddisjonssalt herav, cyanamid eller et substituert cyanamid eller et alkalimetallsalt herav, et salt av 1-guanylpyrazol eller et alkylert guanylpyrazol, som guanylerende middel. where R, R^ and have the same meaning as mentioned above, or a salt thereof, is reacted with an S-alkylisothiourea substance, an O-alkylisothiourea substance or an acid addition salt thereof, cyanamide or a substituted cyanamide or an alkali metal salt thereof, a salt of 1 -guanylpyrazole or an alkylated guanylpyrazole, as guanylating agent.

Fortrinnsvis er det guanylerende middel et S-alkyliso-tiourinstof f eller et syreaddisjonssalt herav, og dette opphetes med aminet eller saltet herav i et inert oppløsningsmiddel for å gi forbindelsen av formelen (I). Preferably, the guanylating agent is an S-alkylisothiourea or an acid addition salt thereof, and this is heated with the amine or salt thereof in an inert solvent to give the compound of formula (I).

Det skal bemerkes at i det britiske patent 933 686 er beskrevet en fremgangsmåte som kan sies å være analog med fremgangsmåten i henhold til foreliggende oppfinnelse, og videre at også forbindelsene som fremstilles i henhold til foreliggende fremgangsmåte har en noe lignende struktur som forbindelsene i henhold til nevnte patent. Imidlertid skal bemerkes at forbindelsene som fremstilles i henhold til det britiske patent omfatter et /3 ,/3-disubstituert pyrrolidin og slike forbindelser er ganske vanskelig å fremstille, mens forbindelsene i henhold til fremgangsmåten ifølge oppfinnelsen ikke omfatter noen slike ter-tiære karbonatomer og de er derfor meget lettere å fremstille. It should be noted that in British patent 933 686 a method is described which can be said to be analogous to the method according to the present invention, and further that the compounds produced according to the present method also have a somewhat similar structure to the compounds according to said patent. However, it should be noted that the compounds produced according to the British patent comprise a /3,/3-disubstituted pyrrolidine and such compounds are quite difficult to produce, while the compounds according to the method according to the invention do not comprise any such tertiary carbon atoms and the is therefore much easier to produce.

Utgangspyrrolidinalkylaminene kan fremstilles ved kata-lytisk hydrogenering i oppløsning av et tilsvarende pyrrol av formelen (III): The starting pyrrolidine alkylamines can be prepared by catalytic hydrogenation in solution of a corresponding pyrrole of the formula (III):

f.eks. ved å anvende en rhodium/aluminiumoksyd-katalysator eller 5 eller 10% Pd/c-katalysator. Når R eller R^er noe annet enn et hydrogenatom, kan det ved denne reaksjon dannes blandinger av cis-trans-isomerer. e.g. by using a rhodium/alumina catalyst or 5 or 10% Pd/c catalyst. When R or R^ is something other than a hydrogen atom, this reaction can form mixtures of cis-trans isomers.

Flere fremgangsmåter kan anvendes for å fremstille pyrrol-alkylaminene av formelen (III) , og særlig: Several methods can be used to prepare the pyrrole-alkylamines of the formula (III), and in particular:

(1) reaksjon av et acetylenisk klorkarbinol (1) reaction of an acetylenic chlorocarbinol

C1CHR . CR2(0H) . CSC^ eller ClCHR . CR2 (0H) . CH2.C<=>CH C1CHR. CR2(0H) . CSC^ or ClCHR . CR2 (0H) . CH2.C<=>CH

med et amin NH2.(CH2)n. NH2. with an amine NH2.(CH2)n. NH2.

(2) Reaksjon av et acetylenisk epoksyd av formelen: (2) Reaction of an acetylenic epoxide of the formula:

med et amin NH2. (CH2)n. NH2. with an amine NH2. (CH2)n. NH2.

(3) Ved å omdanne et pyrrolalkanol av formelen: (3) By converting a pyrrole alkanol of the formula:

til et reaktivt derivat av formelen: to a reactive derivative of the formula:

hvor X er et halogenatom eller resten av en sulfonsyre, særlig toluen-p-sulfonsyre, og denne forbindelse bringes til å reagere med et amin R^N<I>^. where X is a halogen atom or the residue of a sulphonic acid, especially toluene-p-sulphonic acid, and this compound is reacted with an amine R^N<I>^.

Pyrrolidinalkylaminene av formel (II) er også nye forbindelser likesom også et antall av de andre mellomprodukter som her er beskrevet. The pyrrolidine alkylamines of formula (II) are also new compounds, as are a number of the other intermediates described here.

Følgende eksempler skal tjene til å klargjøre oppfinnelsen: The following examples shall serve to clarify the invention:

Eksempel 1 Example 1

4-klormetylpent-l-yn-4-ol (57 g) , vannfritt etylendiamin (150 g, 166 ml) og etanol (150 ml) ble opphetet under tilbakeløp i 17 timer. Oppløsningsmidlet og overskudd av etylendiamin ble fjernet i vakuum og det ble tilsatt 40% vandig natriumhydroksyd (50 ml). Etter fjernelse av vann fra blandingen ved azeotropisk destillasjon med benzen, og fjernelse av oppløsningsmidlet fikk man en olje som ble destillert for å gi l-/3-(aminoetyl) -2,4-di-metylpyrrol (26,9 g, 45%), kp. 72°C ved 0,9 mm, n<*7>,<5>= 1,51,40. 4-Chloromethylpent-1-yn-4-ol (57 g), anhydrous ethylenediamine (150 g, 166 ml) and ethanol (150 ml) were heated under reflux for 17 hours. The solvent and excess ethylenediamine were removed in vacuo and 40% aqueous sodium hydroxide (50 ml) was added. After removal of water from the mixture by azeotropic distillation with benzene, and removal of the solvent, an oil was obtained which was distilled to give 1-(3-(aminoethyl)-2,4-dimethylpyrrole (26.9 g, 45% ), cf. 72°C at 0.9 mm, n<*7>,<5>= 1.51.40.

Dette pyrrol (13,96 g) ble hydrogenert ved romtemperatur og 35 kg/cm 2 trykk i etanol (250 ml) og 5N saltsyre (45 ml) i nær-vær av 5% rhodium/aluminiumoksyd (5 ,0 g) som. katalysator. Etter 60 timer ble katalysatoren filtrert fra og oppløsningsmidlet fjernet i vakuum.Residuet ble oppløst i vann, det ble gjort basisk med fortynnet natriumhydroksydoppløsning, og oppløsningen ble kon-tinuerlig ekstrahert med eter for å gi en olje som ved destillasjon ga l-(/3-aminoetyl)-2,4-dimetylpyrrolidin (6,98 g, 48%) kp. 71°C ved 14 mm, n<*7>= 1,4578. This pyrrole (13.96 g) was hydrogenated at room temperature and 35 kg/cm 2 pressure in ethanol (250 ml) and 5N hydrochloric acid (45 ml) in the presence of 5% rhodium/alumina (5.0 g) as. catalyst. After 60 hours, the catalyst was filtered off and the solvent removed in vacuo. The residue was dissolved in water, basified with dilute sodium hydroxide solution, and the solution was continuously extracted with ether to give an oil which on distillation gave 1-(/3 -aminoethyl)-2,4-dimethylpyrrolidine (6.98 g, 48%) b.p. 71°C at 14 mm, n<*7>= 1.4578.

[Alternativt kan hydrogeneringen utføres under anvendelse av iseddik eller vandig eddiksyre som oppløsningsmiddel istedenfor etanol - 5N saltsyre. Likeledes kan katalysatoren endres fra 5% rhodium/aluminiumoksyd til 5% palladium på benkull eller 10% palladium på benkull. Utbyttene ved hydrogeneringen varierer fra 40-60%.] [Alternatively, the hydrogenation can be carried out using glacial acetic acid or aqueous acetic acid as solvent instead of ethanol - 5N hydrochloric acid. Likewise, the catalyst can be changed from 5% rhodium/alumina to 5% palladium on bone charcoal or 10% palladium on bone charcoal. The yields in the hydrogenation vary from 40-60%.]

Pyrrolidinet (6,59 g) med S-metylisotiouroniumsulfat (6,45 g) i etanol (50 ml) og vann (30 ml) ble behandlet under til-bakeløp i 3 1/2 time. Etter avkjøling ble oppløsningen filtrert, nøytralisert med 5N svovelsyre (10 ml) og inndampet i vakuum for å gi en olje som ved kokning med etanol ga et farveløst, fast stoff. Omkrystallisering fra aceton/vann ga l-(/3-guanidinetyl) -2 ,4-dimetyl-pyrrolidinsulfathydrat (6,46 g, 50%), smp. 291-292°C. (spaltning). The pyrrolidine (6.59 g) with S-methylisothiouronium sulfate (6.45 g) in ethanol (50 mL) and water (30 mL) was refluxed for 3 1/2 hours. After cooling, the solution was filtered, neutralized with 5N sulfuric acid (10 mL) and evaporated in vacuo to give an oil which on boiling with ethanol gave a colorless solid. Recrystallization from acetone/water gave 1-([3-guanidineethyl)-2,4-dimethyl-pyrrolidine sulfate hydrate (6.46 g, 50%), m.p. 291-292°C. (fission).

Eksempel 2 Example 2

4-klormetylheks-l-yn-4-ol (52,2 g), vannfritt etylendiamin (122,0 g, 136 ml) og etanol (200 ml) ble opphetet under til-bakeløp i 30 timer. Opparbeidelse som beskrevet i eksempel 1 ga l-(/3-aminoetyl) -4-etyl-2-metylpyrrol (36,7 g, 68%), kp. 82-87°C/1,3-1,8 mm, nj° = 1,5087 4-Chloromethylhex-1-yn-4-ol (52.2 g), anhydrous ethylenediamine (122.0 g, 136 mL) and ethanol (200 mL) were heated under reflux for 30 h. Workup as described in Example 1 gave 1-((3-aminoethyl)-4-ethyl-2-methylpyrrole (36.7 g, 68%), b.p. 82-87°C/1.3-1.8 mm, nj° = 1.5087

Funnet : 71,0% C 10,5% H 18,3% n Found : 71.0% C 10.5% H 18.3% n

<C>19<H>16N2krever : 71,1% C 10,5% H 18,4% N. <C>19<H>16N2requires : 71.1% C 10.5% H 18.4% N.

Hydrogenering av pyrrolet (33,1 g) under de samme betin-gelser som beskrevet i eksempel 1 gav 1-(/3-aminoetyl) -4-etyl-2-metylpyrrolidin (12,2 g,.36%), kp. 88-89,5°C/15 mm, n^<6>,<5>= 1,4598,karakterisertsom di-toluen-p-sulfonatet, smp. 157-158°c. Hydrogenation of the pyrrole (33.1 g) under the same conditions as described in Example 1 gave 1-(β-aminoethyl)-4-ethyl-2-methylpyrrolidine (12.2 g, 36%), b.p. 88-89.5°C/15 mm, n^<6>,<5>= 1.4598, characterized as the di-toluene-p-sulfonate, m.p. 157-158°c.

Funnet:54,4% C 7,2% H 5,6% N 13,2% S Found: 54.4% C 7.2% H 5.6% N 13.2% S

C23H36<N>2<S>2°6krever : 55,2% C 7,2% H 5,6% N 12,8% S C23H36<N>2<S>2°6requires: 55.2% C 7.2% H 5.6% N 12.8% S

Behandling av'pyrrolidinet (6,0 g) med S-metylisotiouroniumsulfat (5,4 g) i vandig etanol under tilbakeløpsbehandling i 3 timer, etterfulgt av opparbeidelse som beskrevet i eksempel 1, Treatment of the pyrrolidine (6.0 g) with S-methylisothiouronium sulfate (5.4 g) in aqueous ethanol under reflux for 3 hours, followed by work-up as described in Example 1,

ga 1-(j3-guanidinetyl)'-4-etyl-2-metylpyrroiidinsulfat (8,0 g,70%) gave 1-(n3-guanidineethyl)'-4-ethyl-2-methylpyrroidine sulfate (8.0 g, 70%)

smp. 248-250,5°C (spaltning ex-etanol/vann.) m.p. 248-250.5°C (decomposition ex-ethanol/water.)

Funnet : 40,7% C 8,2% H 18,8% N 11,2% S Found : 40.7% C 8.2% H 18.8% N 11.2% S

C10H24N4S04krever : 40,6% C 8,1% H 18,9% N 10,8% S C10H24N4S04requires : 40.6% C 8.1% H 18.9% N 10.8% S

Eksempel 3 Example 3

3- brompropyn (71,5 g, 45 ml) ble oppløst i eter (200 ml) 3-bromopropyne (71.5 g, 45 mL) was dissolved in ether (200 mL)

og en 10 ml's porsjon av oppløsningen ble tilsatt til magnesium- and a 10 ml portion of the solution was added to magnesium

spon (14,65 g) dekket med eter (200 ml). Når reaksjonen var begynt, shavings (14.65 g) covered with ether (200 ml). Once the reaction had started,

ble blandingen avkjølt til -10°C og resten av 3-brompropynoppløs-ningen ble tilsatt dråpevis ved -10°C. l-klor-3,3-dimetylbutan- the mixture was cooled to -10°C and the remainder of the 3-bromopropyne solution was added dropwise at -10°C. l-chloro-3,3-dimethylbutane-

2-on (55,7 g) i benzen (200 ml) ble derpå tilsatt dråpevis og blandingen ble omrørt i ytterligere 4 timer ved -10°C. 5N svovelsyre. 2-one (55.7 g) in benzene (200 mL) was then added dropwise and the mixture was stirred for a further 4 hours at -10°C. 5N sulfuric acid.

(250 ml) ble derpå tilsatt, etterfulgt av vann (250 ml). Etter filtrering ble produktet ekstrahert i eter og eterandelen ble vas- (250 mL) was then added, followed by water (250 mL). After filtration, the product was extracted in ether and the ether portion was

ket med vann, mettet natriumhydrogenkarbonatoppløsning, og slutte- with water, saturated sodium bicarbonate solution, and finally

lig vann. Etter tørring over magnesiumsulfat ble eteren fjernet under redusert trykk. Omhyggelig fraksjonering av den rå olje (65,3 g) medførte utskillelse av 4-klormetyl-5,5-dimetylheks-l-yn-4-ol (4,2 g, 6%) kp. 65-68°C/3,6 mm, n£<4>,<5>= 1,4828, og 4-t-butyl-4,5-epoksypent-l-yn (7,9 g, 14%) kp. 36-38,5°C/3,5 mm, n^<7>= 1,4482. body of water. After drying over magnesium sulfate, the ether was removed under reduced pressure. Careful fractionation of the crude oil (65.3 g) led to the separation of 4-chloromethyl-5,5-dimethylhex-l-yn-4-ol (4.2 g, 6%) bp. 65-68°C/3.6 mm, n£<4>,<5>= 1.4828, and 4-t-butyl-4,5-epoxypent-1-yne (7.9 g, 14%) kp. 36-38.5°C/3.5 mm, n^<7>= 1.4482.

4- klormetyl-5,5-dimetylheks-l-yn-4-ol (3,0 g), vannfritt etylendiamin (6,2 g, 6,7 ml) og etanol (100 ml) ble opphetet under tilbakeløp i 24 timer. Opparbeidelse som beskrevet i eksempel 1 4-chloromethyl-5,5-dimethylhex-l-yn-4-ol (3.0 g), anhydrous ethylenediamine (6.2 g, 6.7 mL) and ethanol (100 mL) were heated under reflux for 24 h . Preparation as described in example 1

ga l-(Ø-aminoetyl)-4-t-butyl-2-metylpyrrol (2,2 g, 71%), kp. 60-62°C/0,05 mm, n^<7>1,5007. gave 1-(O-aminoethyl)-4-t-butyl-2-methylpyrrole (2.2 g, 71%), m.p. 60-62°C/0.05 mm, n^<7>1.5007.

Funnet : 73,1% C 11,3% H 15,1% N Found : 73.1% C 11.3% H 15.1% N

C11H20N2 krever : 7 3,3% C 11,1% H 15,6% N C11H20N2 requires : 7 3.3% C 11.1% H 15.6% N

Alternativt ble 4-t-butyl-4,5-epoksypent-l-yn (6,85 g), vannfritt etylendiamin (17475 g, 19,4 ml) og etanol (100 ml) opphetet under tilbakeløp i 24 timer. Oppløsningsmiddel og oversky-tende etylendiamin ble fjernet i vakuum<p>g vann ble fjernet ved azeotropisk behandling med benzen. Fjernelse av oppløsningsmiddel og destillering gav 1-(/3-aminoetyl) -4-t-butyl-2-metylpyrrol (6,4 g, 72%) o Alternatively, 4-t-butyl-4,5-epoxypent-1-yne (6.85 g), anhydrous ethylenediamine (17475 g, 19.4 mL) and ethanol (100 mL) were heated under reflux for 24 hours. Solvent and excess ethylenediamine were removed in vacuo and water was removed by azeotropic treatment with benzene. Removal of solvent and distillation gave 1-(/3-aminoethyl)-4-t-butyl-2-methylpyrrole (6.4 g, 72%) o

Hydrogenering av pyrrolet (7,0g) under de samme betin-gelser som beskrevet i eksempel 1, gav 1-(/3-aminoetyl) -4-t-butyl-2-metylpyrrolidin (4,3 g, 60%), kp. 105-109°C/14 mm, n^<1>= 1,4618. Hydrogenation of the pyrrole (7.0g) under the same conditions as described in Example 1 gave 1-((3-aminoethyl)-4-t-butyl-2-methylpyrrolidine (4.3g, 60%), bp . 105-109°C/14 mm, n^<1>= 1.4618.

Funnet : 14,8% N Found : 14.8% N

<C>11<H>24<N>2 krever:15,2% N <C>11<H>24<N>2 requires:15.2% N

Behandlingen av pyrrolidinet (3,3 g) med S-metylisotiouroniumsulfat (2,5 g) i vandig etanol under tilbakeløp i 3 1/2 time etterfulgt av opparbeidelse som beskrevet i eksempel 1, gav l-(/3-guanidinetyl)-4-t-butyl-2-metylpyrrolidinsulfat-hemihydrat (4,2 g, 70%), smp. 246-249°C (spaltning) ex-etanol/vann. Treatment of the pyrrolidine (3.3 g) with S-methylisothiouronium sulfate (2.5 g) in aqueous ethanol under reflux for 3 1/2 hours followed by work-up as described in Example 1 gave 1-(/3-guanidineethyl)-4 -t-butyl-2-methylpyrrolidine sulfate hemihydrate (4.2 g, 70%), m.p. 246-249°C (decomposition) ex-ethanol/water.

Funnet s 43,4% C 8,7% H 16,5% N 9,8% S<C>12<H>28N4S04ol//2H2° krever: 43,2% C 8,7% H 16,8% N 9,6% S Found s 43.4% C 8.7% H 16.5% N 9.8% S<C>12<H>28N4S04ol//2H2° requires: 43.2% C 8.7% H 16.8% N 9.6% S

Eksempel 4 Example 4

4-klor-3-metylpent-l-yn-3-ol (143,3 g) og vannfritt etylendiamin (450 g, 500 ml) ble opphetet under tilbakeløp i 6 døgn.Opparbeidelse som beskrevet i eksempel 1 gav 1-(/3-aminoetyl)-2 ,3-dimetylpyrrol (60,0 g, 43%), kp. 72°C/0,9 mm, n<*9>= 1,5162. 4-chloro-3-methylpent-l-yn-3-ol (143.3 g) and anhydrous ethylenediamine (450 g, 500 ml) were heated under reflux for 6 days. Workup as described in example 1 gave 1-(/ 3-aminoethyl)-2,3-dimethylpyrrole (60.0 g, 43%), b.p. 72°C/0.9 mm, n<*9>= 1.5162.

Funnet : 69,75% C 10,3 % H 20,5% N C8H14N2 krever : 69,6 % C 10,15% H 20,3% N Found : 69.75% C 10.3% H 20.5% N C8H14N2 requires : 69.6% C 10.15% H 20.3% N

Hydrogenering av pyrrolet (27,6 g) under de samme betin-gelser som beskrevet i eksempel 1, gav 1-(/3-aminoetyl) -2 ,3-dimetylpyrrolidin (16,0 g, 56,5%), kp. 81-83°C/18 mm, n20 = 1,4640,karakterisertsom dipicratet, smp. 320-321°C. Hydrogenation of the pyrrole (27.6 g) under the same conditions as described in Example 1 gave 1-(β-aminoethyl)-2,3-dimethylpyrrolidine (16.0 g, 56.5%), b.p. 81-83°C/18 mm, n20 = 1.4640, characterized as the dipicrate, m.p. 320-321°C.

Funnet : 40,0% C 4,1% H 18,5% N Found : 40.0% C 4.1% H 18.5% N

<C>20<H>24<N>8°14krever : 40,0% C 4,0% H 18,7% N <C>20<H>24<N>8°14requires : 40.0% C 4.0% H 18.7% N

Behandling av pyrrolidinet (8,0) med S-metylisotiouroniumsulfat (7^8 g) i vandig etanol under tilbakeløp i 5 timer, etterfulgt av opparbeidelse som beskrevet i eksempel 1, gav l-(/3-guanidinetyl)-2,3-dimetylpyrrolidinsulfat-hemihydrat (13,6 g, 86%), smp. 272-274°C (spaltning). Treatment of the pyrrolidine (8.0) with S-methylisothiouronium sulfate (7^8 g) in aqueous ethanol under reflux for 5 hours, followed by work-up as described in Example 1, gave 1-(/3-guanidineethyl)-2,3- Dimethylpyrrolidine sulfate hemihydrate (13.6 g, 86%), m.p. 272-274°C (decomposition).

Funnet : 37,35% C 7,8% H 19,6% N 11,2% S CgH22N4S04.l/2H20 krever : 37,15% C 7,9% H 19,2% N 11,0% S Found : 37.35% C 7.8% H 19.6% N 11.2% S CgH22N4S04.l/2H20 requires : 37.15% C 7.9% H 19.2% N 11.0% S

1-(/3-aminoetyl)-2 , 3-dimetylpyrrolidin fremstilt som beskrevet, erholdes som en blanding av cis og. trans-isomerer i det respektive forhold 65:35. Disse isomerer kan adskilles ved gass-væske-kromatografi under anvendelse av en kolonne av 20% silikon- 1-(/3-aminoethyl)-2,3-dimethylpyrrolidine prepared as described is obtained as a mixture of cis and. trans isomers in the respective ratio 65:35. These isomers can be separated by gas-liquid chromatography using a column of 20% silicone

olje DC 550 på "Celite" og nitrogen som bæregass. oil DC 550 on "Celite" and nitrogen as carrier gas.

Behandling av hver av de rene isomerer for seg med S-metylisotiouroniumsulfat på vanlig måte, etterfulgt av opparbei- Treatment of each of the pure isomers separately with S-methylisothiouronium sulfate in the usual way, followed by working up

delse som beskrevet i eksempel 1, ga cis-2,3-dimetyl-l-(/3-guani-dinetyl)-pyrrolidinsulfat, smp. 292-295°C (spaltning). divide as described in Example 1, gave cis-2,3-dimethyl-1-(β-guanidineethyl)-pyrrolidine sulfate, m.p. 292-295°C (decomposition).

Funnet : 38,6% C 8,0% H 20,0%N 11,4% S<C>9<H>22N4S04krever : 38,3% C 7,8% H 19,9% N 11,35% S Found : 38.6% C 8.0% H 20.0%N 11.4% S<C>9<H>22N4S04 required : 38.3% C 7.8% H 19.9% N 11.35% S

resp. trans-2 , 3-dimetyl-l-(/3-guanidinetyl) -pyrrol i din sul f at-hemi-hydrat, smp„ 294-295°C (spaltning). respectively trans-2,3-dimethyl-1-(/3-guanidineethyl)-pyrrole in din sulfate hemi-hydrate, m.p. 294-295°C (decomposition).

Funnet : 37,4% C 7,8% H 18,7% N 11,0% S C9<H>22N4S04.1/2H20 krever : 37,15%C 7,9% H 19,2% N 11,0% S Found : 37.4% C 7.8% H 18.7% N 11.0% S C9<H>22N4S04.1/2H20 requires : 37.15%C 7.9% H 19.2% N 11, 0% S

Eksempel 5 Example 5

3-klorbutan-2-on (210 g) i benzen (500 ml) ble tilsatt dråpevis til en omrøirt oppløsning av propargylmagnesiumbromid (fremstilt fra 3-brompropyn (357 g, 225 ml) og magnesiumspon (72 3-Chlorobutan-2-one (210 g) in benzene (500 mL) was added dropwise to a stirred solution of propargyl magnesium bromide (prepared from 3-bromopropyne (357 g, 225 mL) and magnesium shavings (72

g) som beskrevet i eksempel 3) i eter ved -10°C. Opparbeidelse som beskrevet i eksempel 3 ga 5-klor-4-metylheks-l-yn-4-ol g) as described in example 3) in ether at -10°C. Workup as described in example 3 gave 5-chloro-4-methylhex-1-yn-4-ol

(230,9 g," 80%) , kp. 35-40°C/0,7-l ,0 mm, n^<9>= 1,4702. (230.9 g," 80%) , b.p. 35-40°C/0.7-l .0 mm, n^<9>= 1.4702.

Funnet : 23,5% Cl Found : 23.5% Cl

C7HllCl° krever : 24,2% Cl C7HllCl° requires: 24.2% Cl

5-klor-4-metylheks-l-yn-4-ol (146,5 g) og etylendiamin 5-chloro-4-methylhex-l-yn-4-ol (146.5 g) and ethylenediamine

(360 g, 400 ml) ble opphetet under tilbakeløp i 3 dager. Opparbeidelse som beskrevet i eksempel 1 ga 1-(/3-aminoetyl) -2 ,3 ,5-trime-tylpyrrol (115,1 g, 76%) kp. 60-65°c/0,01 mm, n£<1>,<5>= 1,5171. (360 g, 400 mL) was heated under reflux for 3 days. Workup as described in Example 1 gave 1-((3-aminoethyl)-2,3,5-trimethylpyrrole (115.1 g, 76%) bp. 60-65°c/0.01mm, n£<1>,<5>= 1.5171.

Funnet : 70,3% C 10,6% H 18,1% N Found : 70.3% C 10.6% H 18.1% N

•<C>9<H>16N2krever : 71,1% C 10,5% H 18,4% N •<C>9<H>16N2requires: 71.1% C 10.5% H 18.4% N

Hydrogenering av pyrrolet (20 g) under de samme betin- Hydrogenation of the pyrrole (20 g) under the same conditions

gelser som beskrevet i eksempel 1, gav 1-(j3-aminoetyl-2 ,3 ,5-tri-metylpyrrolidin (15,6 g, 77%), kp. 78,5-80°C/ll mm, n^° = 1,4995,karakterisertsom dipicratet, smp. 227-228°C. gels as described in Example 1 gave 1-(3-aminoethyl-2,3,5-trimethylpyrrolidine (15.6 g, 77%), b.p. 78.5-80°C/11 mm, n^° = 1.4995, characterized as the dipicrate, mp 227-228°C.

Funnet : 41,0% C 4,3% H 18,4% N Found : 41.0% C 4.3% H 18.4% N

C21H26<N>8°14krever : 41,05%C 4,2% H 18,25% N C21H26<N>8°14requires : 41.05%C 4.2% H 18.25% N

Behandling av pyrrolidinet (7,1 g) med S-metylisotiouroniumsulfat (6,3 g) i vandig etanol under tilbakeløp i 4 timer, etterfulgt av opparbeidelse som beskrevet i eksempel 1, ga l-(/3-guanidinetyl) - >2 ,3,5,-trimetylpyrrolidinsulfat (9,7 g, 72%), smp. 275-278°C(spaltning') ex-etanol/vann. Treatment of the pyrrolidine (7.1 g) with S-methylisothiouronium sulfate (6.3 g) in aqueous ethanol under reflux for 4 h, followed by work-up as described in Example 1, gave l-(/3-guanidineethyl)- >2 , 3,5,-trimethylpyrrolidine sulfate (9.7 g, 72%), m.p. 275-278°C (decomposition') ex-ethanol/water.

Funnet : 40,3% C 8,2% H 18,7% N 10,9% S C10<H>24N4S04krever:40'6% c 8'1^ H 18/9% N 10,8% S Found : 40.3% C 8.2% H 18.7% N 10.9% S C10<H>24N4S04requires:40'6% c 8'1^ H 18/9% N 10.8% S

Eksempel 6 Example 6

Etylmagnesiumbromid (fremstilt fra etylbromid [164,0 g, 113 ml] og magnesiumspon [36,0 g] i eter) ble tilsatt i løpet av 1 time til eter (700 ml) mettet med 1-butyn. Under tilsetningen var den indre temperatur under 10°C og en stadig strøm av 1-butyn ble boblet inn i reaksjonsblandingen. Blandingen ble derpå avkjølt til 5°C, og kloraceton (93 g) ble tilsatt dråpevis. Etter omrøring natten over ved romtemperatur ble mettet ammoniumkloridoppløsning Ethyl magnesium bromide (prepared from ethyl bromide [164.0 g, 113 mL] and magnesium shavings [36.0 g] in ether) was added over 1 hour to ether (700 mL) saturated with 1-butyne. During the addition, the internal temperature was below 10°C and a steady stream of 1-butyne was bubbled into the reaction mixture. The mixture was then cooled to 5°C and chloroacetone (93 g) was added dropwise. After stirring overnight at room temperature, ammonium chloride solution was saturated

(250 ml) forsiktig tilsatt, og det resulterende anorganiske bunn-fall ble frafiltrert og vasket med eter. Filtratet ble vasket med vann, tørret over magnesiumsulfat og inndampet i vakuum, for å gi en olje (136 g). Omhyggelig fraksjonering gav 5-klor-metylheks-3-yn-5-ol (57,5 g, 39%), kp. 81°C/11 mm, n^<1>= 1,4710. (250 mL) was carefully added, and the resulting inorganic precipitate was filtered off and washed with ether. The filtrate was washed with water, dried over magnesium sulfate and evaporated in vacuo to give an oil (136 g). Careful fractionation gave 5-chloro-methylhex-3-yn-5-ol (57.5 g, 39%), b.p. 81°C/11 mm, n^<1>= 1.4710.

Funnet : 57,2% C 7,6% H ,24,5% Cl Found: 57.2% C, 7.6% H, 24.5% Cl

CyH^ClO krever : 57,3% C 7,5% H 24,2%Cl 2-klormetyl-butan-2-ol (24,0 g, 20%) ble også isolert på grunn av reaksjon mellom uendret etylmagnesiumbromid og kloraceton. CyH^ClO requires : 57.3% C 7.5% H 24.2% Cl 2-Chloromethyl-butan-2-ol (24.0 g, 20%) was also isolated due to reaction between unchanged ethylmagnesium bromide and chloroacetone .

5-klormetylheks-3-yn-5^ol (48,8 g), vannfritt etylendiamin (108,0 g, 120,0 ml) og etanol (150 ml) ble opphetet under til-bakeløp i 24 timer. Opparbeidelse som beskrevet i eksempel 1 gav 1-(/3-aminoetyl) -2-etyl-4-me tyl pyrrol (36,8 g, 73%), kp. 79-80°C/ 0,12 mm, n^<1>1,5085. 5-Chloromethylhex-3-yn-5-ol (48.8 g), anhydrous ethylenediamine (108.0 g, 120.0 mL) and ethanol (150 mL) were heated under reflux for 24 hours. Workup as described in Example 1 gave 1-(/3-aminoethyl)-2-ethyl-4-methylpyrrole (36.8 g, 73%), b.p. 79-80°C/ 0.12 mm, n^<1>1.5085.

Funnet : 70,4% C 10,8% H 18,0% N C9H16N2 kre,/er571 c 10,5% H 18,4% N Found : 70.4% C 10.8% H 18.0% N C9H16N2 kre,/er571 c 10.5% H 18.4% N

Hydrogenering av pyrrolet (20 g) under de samme betingel-ser som beskrevet i eksempel 1, gav 1-(/3-aminoetyl) -2-etyl-4-metyl-pyrrolidin (18,1 g, 88%), kp. 82°c/12 mm, n^<1>= 1,4610,karakterisertsom dipicratet, smp. 180-181°C. Hydrogenation of the pyrrole (20 g) under the same conditions as described in Example 1 gave 1-(β-aminoethyl)-2-ethyl-4-methyl-pyrrolidine (18.1 g, 88%), b.p. 82°c/12 mm, n^<1>= 1.4610, characterized as the dipicrate, m.p. 180-181°C.

Funnet : 41,3 %C 4,3% H 18,1 %N Found : 41.3%C 4.3%H 18.1%N

<C>21<H>26<N>8°14krever : 41/05% C 4,2% H 18,25% N <C>21<H>26<N>8°14requires : 41/05% C 4.2% H 18.25% N

Behandling av pyrrolidin (7,6 g) med S-metylisotiouroniumsulfat (6,95 g) i vandig etanol under tilbakeløp i 4 1/2 time, etterfulgt av opparbeidelse som beskrevet i eksempel 1, gav 1-0-guanidinetyl)-2-etyl-4-metylpyrrolidinsulfat (10,6 g, 71%), smp. 272-274°c (spaltning) ex-etanol/vann. Treatment of pyrrolidine (7.6 g) with S-methylisothiouronium sulfate (6.95 g) in aqueous ethanol under reflux for 4 1/2 hours, followed by work-up as described in Example 1, gave 1-O-guanidineethyl)-2- ethyl 4-methylpyrrolidine sulfate (10.6 g, 71%), m.p. 272-274°c (decomposition) ex-ethanol/water.

Funnet : 40,05% C 8,2% H 18,6% N 11,4% S C10H24N4S04krever : 40,6% C 8,1% H 18,9% N 10,8% S Found : 40.05% C 8.2% H 18.6% N 11.4% S C10H24N4S04 required : 40.6% C 8.1% H 18.9% N 10.8% S

Eksempel 7 Example 7

En blanding av l-guanyl-3,5-dimetylpyrazolnitrat og 1-(/3-aminoetyl) -2 ,4-dimetylpyrrolidin (fremstilt som beskrevet i eksempel 1) ble opphetet i 2 1/2 time under omrøring. Overskudd av amin ble fjernet i vakuum, og residuet ble oppløst i vann og om- A mixture of 1-guanyl-3,5-dimethylpyrazole nitrate and 1-(/3-aminoethyl)-2,4-dimethylpyrrolidine (prepared as described in Example 1) was heated for 2 1/2 hours with stirring. Excess amine was removed in vacuo, and the residue was dissolved in water and re-

dannet til det ønskede l-(/3-guanidinetyl) -2 ,4-dimetylpyrrolidin-sulfathydrat ved behandling med en sterk anion(sulfat-)utvekslings-harpiks. Den resulterende oppløsning ble inndampet under redu- formed to the desired 1-(/3-guanidineethyl)-2,4-dimethylpyrrolidine sulfate hydrate by treatment with a strong anion (sulfate) exchange resin. The resulting solution was evaporated under redu-

sert trykk og residuet ble omkrystallisert fra vandig etanol. pressure and the residue was recrystallized from aqueous ethanol.

Produktet var identisk med det som ble oppnådd i henhold til ek- The product was identical to that obtained according to ec-

sempel 1. simple 1.

Eksempel 8 Example 8

En oppløsning av l-(/3-aminoetanol) -2 ,4-dimetylpyrrolidin (fremstilt som beskrevet i eksempel 1) i etanol ble nøytralisert med 5N svovelsyre, det ble tilsatt cyanamid og blandingen ble opphetet under tilbakeløp i 6 timer. Fjernelse av oppløsningsmiddel og omkrystallisering av residuet fra vandig etanol gav l-(/3-guani-dinetyl)-2,4-dimetylpyrrolidin-sulfathydrat, identisk med den forbindelse som ble erholdt i henhold til eksempel 1. A solution of 1-(/3-aminoethanol)-2,4-dimethylpyrrolidine (prepared as described in Example 1) in ethanol was neutralized with 5N sulfuric acid, cyanamide was added and the mixture was heated under reflux for 6 hours. Removal of solvent and recrystallization of the residue from aqueous ethanol afforded 1-(/3-guanidineethyl)-2,4-dimethylpyrrolidine sulfate hydrate, identical to the compound obtained according to Example 1.

Eksempel 9, Example 9,

En oppløsning av l-(0-aminoetyl)-2,4-dimetylpyrrolidin (fremstilt som beskrevet i eksempel 1.) i vann ble nøytralisert med A solution of 1-(0-aminoethyl)-2,4-dimethylpyrrolidine (prepared as described in Example 1.) in water was neutralized with

.5N svovelsyre, det ble tilsatt en ekvivalent mengde av mononatrium-cyanamid, og blandingen ble opphetet under tilbakeløp i 8 timer.Blandingen ble derpå behandlet med en ekvivalent mengde av 5N svo-vélsyre og inndampet i vakuum. Omkrystallisering av residuet fra etanol/vann gav det ønskede 1-(/3-guanidinmetyl) -2 ,4-dimetylpyrrolidin'-sul f athydrat . Produktet var identisk med den forbindelse som .5N sulfuric acid, an equivalent amount of monosodium cyanamide was added, and the mixture was heated under reflux for 8 hours. The mixture was then treated with an equivalent amount of 5N sulfuric acid and evaporated in vacuo. Recrystallization of the residue from ethanol/water gave the desired 1-((3-guanidinemethyl)-2,4-dimethylpyrrolidine'-sulphate hydrate). The product was identical to the compound which

man erholdt i eksempel 1. obtained in example 1.

Eksempel 22 Example 22

1-(/3-aminoetyl)-2 ,4-dimetylpyrrolidin (fremstilt som beskrevet i eksempel 1) og O-metylisouroniumsulfat ble oppløst i vandig etanol og opphetet under tilbakeløp i 4 timer. Etter nøytrali-sering med 5N svovelsyre, ble blandingen inndampet i vakuum og krys-tallisering av residuet fra etanol/vann gav det ønskede l-(/3-guani-dinetyl)-2,4-dimetylpyrrolidin-sulfathydrat. Produktet var identisk med den forbindelse som man erholdt i eksempel 1. 1-(/3-Aminoethyl)-2,4-dimethylpyrrolidine (prepared as described in Example 1) and O-methylisouronium sulfate were dissolved in aqueous ethanol and heated under reflux for 4 hours. After neutralization with 5N sulfuric acid, the mixture was evaporated in vacuo and crystallization of the residue from ethanol/water gave the desired 1-((3-guanidineethyl)-2,4-dimethylpyrrolidine sulfate hydrate). The product was identical to the compound obtained in example 1.

I den nedenfor anførte tabell er innført aktiviteten av visse forbindelser som fremstilles i henhold til foreliggende oppfinnelse sammenlignet med den antihypertensive aktivitet av guanetidin som muligens er det beste antihypertensive middel som for tiden er tilgjengelig. Guanetidin har formelen: In the table below, the activity of certain compounds produced according to the present invention is compared with the antihypertensive activity of guanethidine, which is possibly the best antihypertensive agent currently available. Guanethidine has the formula:

som er den mest aktive forbindelse som fremstilles i henhold til norsk, patent 98 970. which is the most active compound produced according to Norwegian patent 98 970.

Forbindelsene som fremstilles i henhold til oppfinnelsen ble undersøkt subkutant og oralt med hensyn til antihypertensiv aktivitet i hypertensive rotter, og det ble bestemt de doser som medfører et 20%'s fall i blodtrykket. Aktivitetene er gjengitt i forhold til aktiviteten av guanetidin som er gitt verdien 1,00. The compounds produced according to the invention were examined subcutaneously and orally with regard to antihypertensive activity in hypertensive rats, and the doses which cause a 20% drop in blood pressure were determined. The activities are reproduced in relation to the activity of guanethidine, which is given the value 1.00.

Hver forbindelse ble undersøkt som sulfatet. Resultatene er anført for et 65:35 forhold av cis- til trans-isomerer. Each compound was examined as the sulfate. The results are given for a 65:35 ratio of cis to trans isomers.

Claims (1)

Analogifremgangsmåte for fremstilling av pyrrolidino-guanidinforbindelser med verdifulle farmasøytiske egenskaper og med formelen (I): Analogous process for the preparation of pyrrolidino-guanidine compounds with valuable pharmaceutical properties and with the formula (I): og ikke-toksiske syre-addisjonssalter herav, hvor R, R^ og R2hver er hydrogen eller en lavere alkylgruppe, idet dog høyst én av disse substituenter er hydrogen,karakterisertved at et pyrrolidinoalkylamin av formelen (li): and non-toxic acid addition salts thereof, where R, R1 and R2 are each hydrogen or a lower alkyl group, with however at most one of these substituents being hydrogen, characterized in that a pyrrolidinoalkylamine of the formula (li): hvor R, R^og R2har samme betydning som foran nevnt, eller et salt herav, omsettes med et S-alkylisotiourinstoff, et O-alkyliso-urinstoff eller et syre-addisjonssalt herav, cyanamid eller et substituert cyanamid eller et alkalimetallsalt herav, et salt av 1-guanylpyrazol eller et alkylert guanylpyrazol som guanylerende middel.where R, R^ and R2 have the same meaning as mentioned above, or a salt thereof, is reacted with an S-alkylisothiourea, an O-alkylisourea or an acid addition salt thereof, cyanamide or a substituted cyanamide or an alkali metal salt thereof, a salt of 1-guanylpyrazole or an alkylated guanylpyrazole as guanylating agent.
NO04900/68A 1967-12-07 1968-12-06 NO126368B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55708/67A GB1185080A (en) 1967-12-07 1967-12-07 Pyrrolidines

Publications (1)

Publication Number Publication Date
NO126368B true NO126368B (en) 1973-01-29

Family

ID=10474656

Family Applications (1)

Application Number Title Priority Date Filing Date
NO04900/68A NO126368B (en) 1967-12-07 1968-12-06

Country Status (16)

Country Link
AT (1) AT301569B (en)
BE (1) BE725104A (en)
BR (1) BR6804654D0 (en)
CH (1) CH534679A (en)
DE (1) DE1811832A1 (en)
DK (1) DK126781B (en)
ES (1) ES361114A1 (en)
FR (1) FR7874M (en)
GB (1) GB1185080A (en)
IE (1) IE32781B1 (en)
IL (1) IL31228A (en)
IS (1) IS1807A7 (en)
NL (1) NL6817322A (en)
NO (1) NO126368B (en)
SE (1) SE346785B (en)
ZM (1) ZM17068A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3527791A1 (en) * 1985-08-02 1987-02-12 Cassella Ag 2,5-DIMETHYLPYRROL DERIVATIVES, THEIR PRODUCTION AND THEIR USE
TW224974B (en) * 1991-07-02 1994-06-11 Hoffmann La Roche
GB9803536D0 (en) * 1998-02-19 1998-04-15 Black James Foundation Histamine H,receptor ligands

Also Published As

Publication number Publication date
BE725104A (en) 1969-06-06
IL31228A0 (en) 1969-02-27
BR6804654D0 (en) 1973-02-13
GB1185080A (en) 1970-03-18
ES361114A1 (en) 1970-08-01
CH534679A (en) 1973-03-15
FR7874M (en) 1970-04-27
ZM17068A1 (en) 1969-06-17
NL6817322A (en) 1969-06-10
DE1811832A1 (en) 1969-07-03
IL31228A (en) 1972-04-27
IS1807A7 (en) 1969-01-22
SE346785B (en) 1972-07-17
AT301569B (en) 1972-09-11
DK126781B (en) 1973-08-20
IE32781B1 (en) 1973-11-28
IE32781L (en) 1969-06-07

Similar Documents

Publication Publication Date Title
SU793382A3 (en) Method of preparing triphenylalkene derivatives or their salts
DK158307B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 4- (PHENYLALKYL) IMIDAZOLD DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF
CH648553A5 (en) NEW 3,4-DIHYDRO-5H-2,3-BENZODIAZEPINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
DK145260B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 4-ACYLAMINO-PHENYL-ETHANOLAMINES OR ACID ADDITION SALTS
CS241016B2 (en) Method of new n-(2-(or)pyrrolidinylmethyl)-benzamides production substituted in positions 2,3,4,5,6
NO860285L (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOLD DERIVATIVES.
DE68924751T2 (en) Azacyclic compounds useful as medicines.
NO313196B1 (en) Pyrimidinylpyrazole derivative, and anti-tumor agent containing it
DE1595920A1 (en) 4- (omega-piperazinoalkyl) pyrazoles, their salts and processes for their preparation
US4094987A (en) 2-(3-m-hydroxy-phenyl-1-substituted-3-pyrrolidinyl)-ethanols
NO126368B (en)
SU683623A3 (en) Method of the preparation of purine derivatives or their salts
US2617825A (en) Process for preparation of salts of 1-amino-2-haloethanes
DE69501791T2 (en) INDOL DERIVATIVES AS 5-HT1 LIKE AGONISTS
Corrigan et al. Preparation of N-substituted 1-(p-hydroxyphenyl)-2-aminoethanols1
JPS5934709B2 (en) Method for producing chlorinated imidazole derivatives
US3903104A (en) 1-(2-{66 {HU 2{B -Imidazolinyl)-2,2-diarylcyclopropanes and process
DE3750117T2 (en) Process for the preparation of indolinone-2 derivatives.
EP0025501B1 (en) N-aminoalkyl indole derivatives and their salts, processes for their preparation and medicaments containing these compounds
EP1124805B1 (en) Method for producing 4-[(2&#39;,5&#39;- diamino-6&#39;- halopyrimidine- 4&#39;-yl)amino]- cyclopent- 2-enylmethanols
Katritzky et al. Synthesis and reactions of lithio derivatives of 1‐allenylbenzotriazole
DE2409313A1 (en) NEW PYRROLYL COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION
IE52102B1 (en) Indole and indoline derivatives
US2782191A (en) Nitrogen containing carbinols
SU655307A3 (en) Method of obtaining guanidine derivatives or salts thereof